EQS-News

H&R GmbH & Co. KGaA publishes Annual Report 2023 - Seite 3

Dividend proposal to the Annual General Meeting planned

H&R GmbH & Co. KGaA has achieved a distributable result according to HGB for 2023. The company's management will again propose to the Annual General Meeting that a dividend of EUR 0.10 per share be distributed.

Outlook

We are currently formulating our expectations for 2024 with an operating result (EBITDA) in the range of € 90.0 million to € 110.0 million but reserve the right to adjust these expectations during the year and in consideration of further business developments. For a complete presentation of business performance, including segment reporting and the annual financial statements, H&R KGaA refers to the 2023 Annual Report published today at www.hur.com - Investors - Publications.

Contact:
H&R GmbH & Co. KGaA, Head of Investor Relations / Communication, Ties Kaiser
Neuenkirchener Straße 8, 48499 Salzbergen
Phone.: [phone], Fax: [phone]
Mail: [e-mail]
www.hur.com

H&R GmbH & Co. KGaA:

Listed in the Prime Standard of the Frankfurt Stock Exchange, H&R GmbH & Co. KGaA is a specialty chemicals company active in the development and manufacture of chemical-pharmaceutical specialty products based on fossil, bio-based, synthesized and recycled hydrocarbons and in the production of precision plastic parts.

 

Forward-looking statements and forecasts:

This insider information pursuant to Article 17 of the Market Abuse Regulation [MAR] contains forward-looking statements. The statements are based on the current estimates and forecasts by the Management Team and the information available to it at this time. These forward-looking statements do not provide any warranty for the future developments and results contained therein. The future developments and results are dependent on a number of factors; they entail various risks and contingencies and are based on assumptions which could prove to be incorrect. We do not assume any responsibility for updating the forward-looking statements contained in this insider information pursuant to Article 17 of the MAR.